Dementia (Alzheimer's, vascular)

Dementia — putting it down to aging costs you the window

Dementia — putting it down to aging costs you the window — Source: MBN News · Survey data: Korea Medical & Bio Reporters Association, Korean Dementia Association

Source : MBN News · Survey data: Korea Medical & Bio Reporters Association, Korean Dementia Association

Of all dementia, 70% is Alzheimer's disease, the toxic protein Amyloidattacks neurons as it progresses.

Next is vascular dementia arising from cerebrovascular disease; Lewy body disease, Parkinson's disease, alcohol-related and metabolic causes such as thyroid disease, and hydrocephalus are also responsible.

Yet the point at which people come in as the condition progresses 45.7% come only once daily life is already affected, while just 28.6% come at a very early stage. The reasons for delay are believing it to be natural aging (45.2%) and fear of receiving a diagnosis (26.3%).

The new Alzheimer's agents are Indicated for mild cognitive impairment through early dementia, so the timing of diagnosis is what determines the range of options. Because both treatment and outcome depend on the cause, Do not delay — start by finding the cause.

Dementia — how is it diagnosed and treated?

Dementia — how is it diagnosed and treated?

Dementia is a state in which cognitive decline has reached the point of impairing independent daily living; early on it begins with memory impairment and personality change. Alzheimer's disease and vascular dementia are the most common forms, and the two frequently coexist. Other causes include Lewy body disease, Parkinson's disease, alcohol-related dementia, metabolic causes such as thyroid disease, and hydrocephalus. Treatment and outcome vary enormously with the underlying cause of dementia, so accurately diagnosing which cause underlies it is the starting point for treatment, prevention, and management.

In Korea in particular, where cerebrovascular disease is common, preventing vascular dementia matters all the more, and Brain MRI and MRA establish whether cerebrovascular stenosis is present and whether there is a risk of vascular dementia, and Controlling hypertension and diabetes, stopping smoking and moderating alcohol, and checking and correcting dyslipidemia, inflammation, and homocysteine on blood testing, stroke and vascular dementia must be prevented together.
In-depth neuropsychological testing · brain MRI and MRA · blood tests identify the cause the same day wherever possible, and Medication (acetylcholinesterase inhibitors, NMDA receptor antagonists) · anti-amyloid therapy · cognitive rehabilitation · TMS — we provide whichever is appropriate.

※ This is general medical information provided for understanding only. Actual diagnosis and treatment are determined by a specialist after examination, based on the individual patient's condition.

Advanced Equipment

  • SIEMENS3T AI MRIWe add AI imaging (Deep Resolve) to a proven Siemens 3T MRI to examine neurological conditions faster and more clearly.
  • MRACerebrovascular and carotid MRAIt accurately evaluates the degree of atherosclerosis, stenosis, structural abnormality, and the presence of aneurysm in the vessels of the brain and neck.
  • Carotid USCarotid UltrasoundCarotid wall thickness and plaque are examined to assess stroke risk.
  • NCS / EMGNerve conduction studiesNerves in the arms, legs, and face are safely stimulated electrically and the responses recorded, establishing whether peripheral nerve damage is present and how severe it is.
  • EPEvoked potential testBy safely stimulating the visual and auditory pathways electrically, damage to the cranial nerves can be identified.
  • EEGAI digital EEGBeyond the conventional identification of epileptiform waveforms, quantitative EEG with the latest AI software aids in assessing brain function in headache, anxiety, and depression.
  • VNGVideo nystagmographyBy recording and analyzing involuntary eye movement on video, this test is useful for distinguishing dizziness disorders such as BPPV and Meniere's disease.
  • HRV / SSRAutonomic Function TestEquipment that objectively assesses the balance between the body's sympathetic and parasympathetic nerves.
  • PWV / ABIArterial elasticity testingBy measuring vessel elasticity and the degree of atherosclerosis, it readily assesses the risk of circulatory disturbance and cardiovascular or cerebrovascular disease.
  • Wearable ECG/BPWearable cardiac function testingA micro-sensor continuously analyzes blood pressure and ECG over 24 hours to identify cardiac dysfunction capable of causing a stroke.
  • SNSB / CERADNeuropsychological testingIt distinguishes simple forgetfulness from dementia and objectively evaluates cognitive function including memory.
  • LABBlood and genetic testingWe identify risk factors for cardiovascular and cerebrovascular disease, including dyslipidemia, and look for high-risk dementia genes in advance so that prevention can begin.